Business Context and Reporting Period
Company: Amgen Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: August 5, 2025
Reporting Period: Unaudited results for the three and six months ended June 30, 2025.
This filing announces the issuance of a press release (Exhibit 99.1) detailing the Company's second-quarter 2025 earnings and financial position. The report includes both GAAP and non-GAAP financial measures.
Key Financial Metrics
The filing text serves as a notification of the earnings release and defines the methodology for non-GAAP measures but does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. The following metrics are referenced as being included in the attached press release:
- Non-GAAP Measures: Earnings per share, operating income, operating margin, tax rate, and operating expenses (including cost of sales, R&D, and SG&A).
- Liquidity: Free Cash Flow (FCF), calculated as operating cash flow minus capital expenditures.
- Debt: The registrant lists "2.000% Senior Notes due 2026" as a registered security, though outstanding balances are not detailed in this text.
Material Changes and Adjustments
The filing outlines specific adjustments made to GAAP results to derive non-GAAP figures, which facilitate comparisons of ongoing business operations. These adjustments exclude:
- Acquisition-related expenses: Amortization and impairment of intangible assets (e.g., technology rights, licensing rights) and step-up to fair value of acquired inventory.
- Restructuring and cost savings initiatives: Facilities charges, asset impairments, accelerated depreciation, and severance/benefits for terminated employees.
- Other items: Gains and losses on equity securities and certain items associated with legal proceedings.
The tax effect of these adjustments is calculated based on the applicable tax treatment and rates in relevant jurisdictions.
Guidance, Outlook, and Management Commentary
Management Commentary: Management utilizes non-GAAP measures for internal budgeting, financial planning, resource allocation, and evaluating performance against incentive compensation targets. The Company asserts that excluding acquisition-related and restructuring charges treats acquired assets comparably to internally developed assets.
Guidance and Risks: This specific 8-K text does not contain forward-looking guidance, specific risk factors, or contingency details beyond the general note that restructuring costs may be incurred in the future and that acquisition charges vary based on timing and magnitude.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for the actual numerical values of Q2 2025 revenue, net income, and EPS.
- Verify the reconciliation tables in the press release to understand the magnitude of the excluded acquisition and restructuring charges.
- Confirm the specific Free Cash Flow (FCF) figure and capital expenditure amounts reported in the press release.
- Check for any updated forward-looking guidance or product pipeline updates included in the full press release text.